J. Anthony Parker - Concepedia

Author

J. Anthony Parker

Also Known As

Alexander Gray, Betty C. Tong, C Harding, J A PARKER, J A Parker, J Anthony Parker, J Parker, J. A. Parker, J. ANTHONY PARKER, J. Anthony Parker

173

Publications

7.3K

Citations

H-Index

136

Concepts

All Affiliations

Harvard University Beth Israel Deaconess Medical Center Beth Israel Deaconess Hospital Brigham and Women's Hospital Harvard University Press

About

J. Anthony Parker is an author at Harvard University specializing in medicine, cardiology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	45	4.5K
2	Health Sciences	13	15	817
3	Engineering	4	4	139
4	Education	2	2	47
5	Nursing	1	1	276

J. Anthony Parker

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Samuel Z. Goldhaber, Patricia C. Come, R.T. Lee, The Lancet ThrombosisPulmonary EmbolismVenous ThrombosisPulmonary CirculationCardiovascular Disease	1993	840
Procedure guideline for tumor imaging with F-18 FDG PET/CT Dominique Delbeke, R. Edward Coleman, Milton J. Guiberteau,	2006	628
RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM SamuelZ. Goldhaber, John A. Heit, G.V.R.K. Sharma, The Lancet ThrombosisTranslational MedicinePulmonary EmbolismVenous ThrombosisFibrinolysis	1988	368
Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure Donald S. Baim, Arthur V. McDowell, Joseph Cherniles, New England Journal of Medicine HypertensionHeart FailureCardiac AnaesthesiaLeft Ventricular PressureCardiovascular Pharmacology	1983	341
Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial Infarction John E. Markis, Michael Malagold, J. Anthony Parker, New England Journal of Medicine	1981	280
The SNMMI Practice Guideline for Therapy of Thyroid Disease with <sup>131</sup>I 3.0 Edward B. Silberstein, Abass Alavi, Helena Balon, Journal of Nuclear Medicine Snmmi Practice GuidelineUnited StatesRisk Levels……2 IvPerioperative SafetyPublic Health	2012	276
Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with <sup>18</sup>F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation Joanna J. Wykrzykowska, Sanaz Lehman, Gethin Williams, Journal of Nuclear Medicine	2009	263
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial Samuel Z. Goldhaber, Craig M. Kessler, John A. Heit, Journal of the American College of Cardiology Pulmonary EmbolismTranslational MedicineThrombosisVenous ThrombosisFibrinolysis	1992	218
Relation of Duration of Symptoms With Response to Thrombolytic Therapy in Pulmonary Embolism Lori B. Daniels, J. Anthony Parker, Sanjay R. Patel, The American Journal of Cardiology Pulmonary EmbolismThrombosisThrombolytic TherapyCoagulopathyMedicine	1997	209
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma Gregory A. Wiseman, Christine A. White, Richard Sparks, Critical Reviews in Oncology/Hematology Lymphoid NeoplasiaRadiation MedicineOncologyDosimetry ResultsRadiation Therapy	2001	183

Page 1